Jane Wang
Directeur Technique/Scientifique/R&D chez APOLLOMICS, INC.
Profil
Jane Wang currently works at Apollomics, Inc. (United States), as Chief Scientific Officer and Apollomics, Inc., as Chief Scientific Officer from 2023.
Dr. Wang also formerly worked at Pfizer Inc., as Principal and WuXi AppTec Co., Ltd., as Vice President-Medicinal Chemistry from 2010 to 2022.
Dr. Wang received her doctorate degree from the University of Maryland and undergraduate degree from Fudan University.
Postes actifs de Jane Wang
| Sociétés | Poste | Début |
|---|---|---|
| APOLLOMICS, INC. | Directeur Technique/Scientifique/R&D | 30/03/2023 |
Apollomics, Inc. (United States)
 Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Jane Wang
| Sociétés | Poste | Fin |
|---|---|---|
| WUXI APPTEC CO., LTD. | Corporate Officer/Principal | 01/07/2022 |
| PFIZER, INC. | Corporate Officer/Principal | - |
Formation de Jane Wang
| Fudan University | Undergraduate Degree |
| University of Maryland | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| APOLLOMICS, INC. | Health Technology |
| WUXI APPTEC CO., LTD. | Health Technology |
| PFIZER, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Apollomics, Inc. (United States)
Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Health Technology |